- Home
- FTW vs ZVRA Comparison
FTW vs ZVRA Comparison
Compare FTW & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$10.36
Company Overview
Basic Information| Metric | FTW | ZVRA |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.2M | 472.9M |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FTW | ZVRA |
|---|---|---|
| Price | $10.92 | $10.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 111.2K | ★ 665.1K |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 159.21 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $106,470,000.00 |
| Revenue This Year | N/A | $37.27 |
| Revenue Next Year | N/A | $53.42 |
| P/E Ratio | ★ N/A | $7.65 |
| Revenue Growth | N/A | ★ 350.91 |
| 52 Week Low | $9.50 | $6.85 |
| 52 Week High | $17.20 | $13.16 |
Technical Indicators
Market Signals| Indicator | FTW | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.82 | 64.60 |
| Support Level | $9.50 | $8.29 |
| Resistance Level | $13.83 | $11.19 |
| Average True Range (ATR) | 0.52 | 0.39 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 53.31 | 88.68 |
Price Performance
Historical Comparison FTW
ZVRA
About FTW EQV Ventures Acquisition Corp. Class A Ordinary Shares
EQV Ventures Acquisition Corp is a blank check company.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.